199 related articles for article (PubMed ID: 10632639)
1. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
Corrigan G; Stevens PE
Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
[TBL] [Abstract][Full Text] [Related]
2. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
Frandsen NE; Saugmann S; Marcussen N
Nephron; 2002 Sep; 92(1):200-2. PubMed ID: 12187103
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
[No Abstract] [Full Text] [Related]
4. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.
Moss JG; Parry CM; Holt RCL; McWilliam SJ
Eur J Med Res; 2022 Apr; 27(1):61. PubMed ID: 35488310
[TBL] [Abstract][Full Text] [Related]
5. Mesalazine-associated interstitial nephritis.
World MJ; Stevens PE; Ashton MA; Rainford DJ
Nephrol Dial Transplant; 1996 Apr; 11(4):614-21. PubMed ID: 8671848
[TBL] [Abstract][Full Text] [Related]
6. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Ransford RA; Langman MJ
Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
[TBL] [Abstract][Full Text] [Related]
7. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
[TBL] [Abstract][Full Text] [Related]
8. Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
Shahrani Muhammad HS; Peters C; Casserly LF; Dorman AM; Watts M
Clin Nephrol; 2010 Mar; 73(3):250-2. PubMed ID: 20178728
[TBL] [Abstract][Full Text] [Related]
9. Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease.
Uslu N; Demir H; Saltik-Temizel IN; Topaloğlu R; Gürakan F; Yüce A
Dig Dis Sci; 2007 Nov; 52(11):2926-9. PubMed ID: 17404867
[TBL] [Abstract][Full Text] [Related]
10. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
Bosque López MJ; Garrido Durán C; Ginard Vicens D; Munar Vila MA; Vanrell Garau M; Mariño Méndez Z; Gayà Cantallops J
Gastroenterol Hepatol; 2009 Jan; 32(1):29-31. PubMed ID: 19174096
[TBL] [Abstract][Full Text] [Related]
11. Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.
Sari I; Birlik M; Cavdar C; Sarioglu S; Akpinar H; Onen F; Akkoc N
N Z Med J; 2005 Sep; 118(1222):U1662. PubMed ID: 16222356
[No Abstract] [Full Text] [Related]
12. The Association of Mesalamine With Kidney Disease.
Adiga A; Goldfarb DS
Adv Chronic Kidney Dis; 2020 Jan; 27(1):72-76. PubMed ID: 32147005
[TBL] [Abstract][Full Text] [Related]
13. [Chronic interstitial nephritis and mesalazine: 3 new cases?].
Brouillard M; Gheerbrant JD; Gheysens Y; Fleury D; Devred M; Hazzan M; Colombel JF
Gastroenterol Clin Biol; 1998; 22(8-9):724-6. PubMed ID: 9823562
[TBL] [Abstract][Full Text] [Related]
14. Chronic interstitial nephritis due to 5-aminosalicylic acid.
Agharazii M; Marcotte J; Boucher D; Noël R; Lebel M
Am J Nephrol; 1999; 19(3):373-6. PubMed ID: 10393373
[TBL] [Abstract][Full Text] [Related]
15. Mesalazine-induced interstitial nephritis.
Skalova S; Dedek P; Pozler O; Podhola M
Ren Fail; 2009; 31(2):159-61. PubMed ID: 19212915
[TBL] [Abstract][Full Text] [Related]
16. [Interstitial nephritis induced by mesalazine].
Ohya M; Otani H; Kimura K; Kodama N; Minami Y; Liang XM; Maeshima E; Yamada Y; Mune M; Yukawa S
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):414-9. PubMed ID: 12073628
[TBL] [Abstract][Full Text] [Related]
17. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
Laboudi A; Makdassi R; Cordonnier C; Fournier A; Choukroun G
Nephrologie; 2002; 23(7):343-7. PubMed ID: 12500420
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
Gisbert JP; González-Lama Y; Maté J
Inflamm Bowel Dis; 2007 May; 13(5):629-38. PubMed ID: 17243140
[TBL] [Abstract][Full Text] [Related]
19. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
20. 5-ASA therapy and renal function in inflammatory bowel disease.
Siveke JT; Egert J; Sitter T; Schiemann U; Walcher P; Török HP; Glas J; Folwaczny C
Am J Gastroenterol; 2005 Feb; 100(2):501. PubMed ID: 15667517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
